Drug Efficacy
This page lists 101 references in the Main Healthy Skepticism Library relevant to Drug Efficacy.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL6798
Tandon R.
Comparing antipsychotic efficacy.
Am J Psychiatry 2006 Sep 01;163(9):1645
http://ajp.psychiatryonline.org/cgi/content/full/163/9/1645
HSL6880
Lowe JA 3rd, Duckworth M, Jones P.
Innovation, productivity and the art of risk management.
Curr Opin Drug Discov Devel 2006 Sep 01;9(5):549-50
HSL6837
Kabra SK, Lodha R.
Irrational combination of montelukast and bambuterol for management of childhood asthma.
Indian Pediatr 2006 Aug 01;43(8):743-4
http://www.indianpediatrics.net/aug2006/743.pdf
HSL6202
Roehr B.
Institute of Medicine report strives to reduce medication errors
BMJ 2006 Jul 29;333(7561):220
http://bmj.bmjjournals.com/cgi/content/short/333/7561/220-f?etoc%3e
HSL6846
McHenry L.
Ethical issues in psychopharmacology.
J Med Ethics 2006 Jul 01;32(7):405-10
http://jme.bmjjournals.com/cgi/content/full/32/7/405
HSL6704
Ansani N, Sirio C, Smitherman T, Fedutes-Henderson B, Skledar S, Weber RJ, Zgheib N, Branch R.
Designing a strategy to promote safe, innovative off-label use of medications.
Am J Med Qual 2006 Jul-Aug 01;21(4):255-61
http://ajm.sagepub.com/cgi/reprint/21/4/255
HSL6705
Ansani N, Branch R, Fedutes-Henderson B, Smitherman T, Weber RJ, Skledar S, Zgheib N, Sirio C.
United States medical practice summary: innovative off-label medication use.
Am J Med Qual 2006 Jul-Aug 01;21(4):246-54
http://ajm.sagepub.com/cgi/reprint/21/4/246
HSL5722
Eaton L.
European agency approves use of fluoxetine for children and teens.
BMJ 2006 Jun 17;332(7555):1407
http://bmj.bmjjournals.com/cgi/content/short/332/7555/1407-a?etoc
HSL5531
Emslie GJ, Wagner KD, Kutcher S, Krulewicz S, Fong R, Carpenter DJ, Lipschitz A, Machin A, Wilkinson C.
Paroxetine Treatment in Children and Adolescents With Major Depressive Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial.
J Am Acad Child Adolesc Psychiatry 2006 Jun 01;45(6):709-719
Link to source with long URL
HSL5734
Alberti H.
Inhaled insulin: evidence based or industry driven medicine?
BMJ 2006 May 27;332(7552):1273
Link to source with long URL
HSL5576
Hass DJ, Lewis JD.
Quality of manufacturer provided information on safety and efficacy claims for dietary supplements for colonic health.
Pharmacoepidemiol Drug Saf 2006 May 15
Link to source with long URL
HSL6224
Collis MC.
Integrative pharmacology and drug discovery--is the tide finally turning?
Nat Rev Drug Discov 2006 May 01;5(5):377-9
Link to source with long URL
HSL6758
Bignone IM.
[Issues regarding the legal regulation of drugs in Argentina].
Vertex 2006 May-Jun 01;17(67):220-3
HSL5520
Busfield J.
Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry
2006;40(2):297-314
http://soc.sagepub.com/cgi/content/abstract/40/2/297?etoc
HSL5607
Lacasse JR, Leo J.
Serotonin and depression: a disconnect between the advertisements and the scientific literature.
PLoS Med 2005 Dec;2(12):e392
Link to source with long URL
HSL2931
Lieberman J.
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
New England Journal of Medicine 2005 Sep 22;353(no. 12)
http://content.nejm.org/cgi/reprint/NEJMoa051688.pdf
HSL6841
Nyigo VA, Malebo HM.
Drug discovery and developments in developing countries: bottlenecks and way forward.
Tanzan Health Res Bull 2005 Sep 01;7(3):154-8
HSL6016
Mansfield PR, Jureidini JN.
Re: Fluoxetine for depressed adolescents: harms likely to exceed benefits
BMJ 2005 Aug 16;330
http://bmj.bmjjournals.com/cgi/eletters/330/7493/730-b
HSL4184
Carney S.
Question: what do you call 500 scientists coming together to address the productivity gap? Answer: a start.
Drug Discov Today 2005 Aug 01;10(15):1025-9
Link to source with long URL
HSL2247
Safety and Efficacy of SSRIs in Children and Adolescents
American Medical Association 2005 Jun 29
http://www.ama-assn.org/ama/pub/category/print/15186.html
HSL4231
Guaiana G, Andretta M, Corbari L, Mirandola M, Sorio A, D'Avanzo B, Barbui C.
Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000.
J Clin Psychiatry 2005 Jun 01;66(6):750-5
Link to source with long URL
HSL4237
Diller L.
Antidepressants and children's depression.
Am J Psychiatry 2005 Jun 01;162(6):1226-7
http://ajp.psychiatryonline.org/cgi/content/full/162/6/1226-a
HSL1867
Carey B.
F.D.A. Considers Implant Device for Depression
The New York Times 2005 May 21
HSL1866
Wilde-mathews A.
Brain Neurostimulation Shown to Relieve Severe Depression for Some: Ruling on Medical Device Examined
THE WALL STREET JOURNAL 2005 May 19
HSL4219
Hamrin V, Scahill L.
Selective serotonin reuptake inhibitors for children and adolescents with major depression: current controversies and recommendations.
Issues Ment Health Nurs 2005 May 01;26(4):433-50
HSL4251
Longstaff C, Thelwell C, Whitton C.
The poor quality of streptokinase products in use in developing countries.
J Thromb Haemost 2005 May 01;3(5):1092-3
Link to source with long URL
HSL5449
Kaltwasser JP, Behrens F.
Leflunomide: long-term clinical experience and new uses.
Expert Opin Pharmacother 2005 May 01;6(5):787-801
Link to source with long URL
HSL5459
Litten RZ, Fertig J, Mattson M, Egli M.
Development of medications for alcohol use disorders: recent advances and ongoing challenges.
Expert Opin Emerg Drugs 2005 May 01;10(2):323-43
http://www.expertopin.com/doi/abs/10.1517/14728214.10.2.323
HSL5512
Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ.
The global threat of counterfeit drugs: why industry and governments must communicate the dangers.
PLoS Med 2005 Apr 01;2(4):e100
Link to source with long URL
HSL6017
Mansfield PR, Jureidini JN, Parry P.
The belief that fluoxetine is effective for depressed children persists but is unjustified
BMJ 2004 Dec 31;330
http://bmj.bmjjournals.com/cgi/eletters/330/7481/7
HSL488
Jureidini J, Tonkin A, Mansfield PR.
TADS study raises concerns.
BMJ 2004 Dec 4;329(7478):1343-4
http://bmj.bmjjournals.com/cgi/content/full/329/7478/1343-d
HSL5394
Turner EH.
A taxpayer-funded clinical trials registry and results database.
PLoS Med 2004 Dec;1(3):e60
Link to source with long URL
HSL1373
L-carnitine
Med Lett Drugs Ther 2004 Nov 22;46(1196):95-6
HSL6019
Mansfield PR.
Reply to Stephen Black and Nicholas DeMartinis
2004 Oct 15;329
http://bmj.bmjjournals.com/cgi/eletters/329/7468/748
HSL6021
Mansfield PR.
Clarification and Update for AdWatch on Nexium dialogue
BMJ 2004 Apr 30;328
http://bmj.bmjjournals.com/cgi/eletters/328/7447/1035-a
HSL5881
Kaufman R.
The Neurontin Controversy: The Saga of Off-Label Drug Regulation Continues
Legal Electronic Document Archive: Harvard Law School 2004 Apr 1
http://leda.law.harvard.edu/leda/data/638/Kaufman.html
HSL2782
Goldman SA.
Communication of medical product risk: how effective is effective enough?
Drug Saf 2004;27(8):519-34
HSL1427
Katz A.
Observations and advertising: controversies in the prescribing of hormone replacement therapy
Health Care Women Int 2003 Dec;24(10):927-39
HSL2238
Moncrieff J.
Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination
Br J Psychiatry. 2003 Aug;183:161-6
http://bjp.rcpsych.org/cgi/content/full/183/2/161
HSL1439
Fugh-Berman A.
"Bust enhancing" herbal products.
Obstet Gynecol 2003 Jun;101(6):1345-9
http://www.greenjournal.org/cgi/content/full/101/6/1345
HSL1661
Jureidini J, Tonkin A.
Paroxetine in major depression.
J Am Acad Child Adolesc Psychiatry 2003 May;42(5):514
Link to source with long URL
HSL1466
Bonnemain B.
[When blood and meat were drugs]
Rev Hist Pharm (Paris).2003;51(340):611-24 2003;51(340):611-24
HSL6145
Russell FM, Shann F, Curtis N, Mulholland K.
Evidence on the use of paracetamol in febrile children.
Bull World Health Organ 2003;81(5):367-72
Link to source with long URL
HSL2912
[No authors listed].
Is Yasmin a 'truly different' drug?
Drug Ther Bull 2002 Aug;40(8):57-9
Link to source with long URL
HSL4285
Is Yasmin a "truly different" pill?
Drug Ther Bull 2002;40(8):57-9
Link to source with long URL
HSL2968
Hrachovec J, Mora M.
Reporting of 6-month vs 12-moth data in a clinical trial of celecoxib [1st of 3 letters]
JAMA 2001 Nov 21;286(19):2398
http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html
HSL2769
Høgh B, Clarke PD, Camus D, Chulay JD
Efficacy of atovaquone-proguanil?
The Lancet 2001 Apr 21;357:1289-1290
HSL2969
Hogh B, Clarke PD, Camus D, Chulay JD.
Efficacy of atovaquone-proguanil? (2nd of 2 letters)
The Lancet 2001 Apr 21;357:1289-1290
HSL2975
Croft A, Geary K, Morgan L.
Efficacy of atovaquone-proguanil? (1st of 2 letters)
The Lancet 2001 Apr 21;357:1289
HSL350
Freemantle N, Anderson IM, Young P.
Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis.
Br J Psychiatry 2000 Oct;177:292-302
http://bjp.rcpsych.org/cgi/content/full/177/4/292
HSL8517
Kizer JR, Kimmel SE.
Calcium channel blocker controversy: historical perspective and important lessons for future pharmacotherapies-International Society of Pharmacoepidemiology hot topic
Pharmacoepidemiology and Drug Safety 2000;9(1):25-36
HSL527
Melzer D.
New drug treatment for Alzheimer's disease: lessons for healthcare policy.
BMJ 1998 Mar 7;316(7133):762-4
http://bmj.bmjjournals.com/cgi/content/full/316/7133/762
HSL733
Christo GG, Balasubramaniam R.
Commentary: advertising adversities.
BMJ 1997 Aug 23;315(7106):460
http://www.bmj.com/cgi/content/full/315/7106/460
HSL672
Sukkari SR.
Weighing benefits and risks of drug to treat obesity.
CMAJ 1997 Mar 15;156(6):768-9
http://www.cmaj.ca/cgi/reprint/156/6/768
HSL808
Alliot LS.
Criticism of Servier re perindopril.
Lancet 1996 Mar 23;347(9004):832
HSL5549
Drug promotion: stealth, wealth, and safety
The Lancet 1993;341:1507-1508
HSL5132
Re: the promotion of aspirin
1992 Nov 1
HSL4740
Industry promotions: institutionalized deception
Drug Monitor 1991 May;6(5):49-51
HSL4682
Mansfield PR.
Classifying improvements to drug marketing and justifications for claims of efficacy
International Journal of Risk & Safety in Medicine 1991;2:171-184
HSL4631
Saade C, Huff-rousselle M.
Pakistan: should ORS be marketed like other drugs?
Dialogue on Diarrhoea 1990 Sep(42):6
HSL4493
Re: the promotion of uridine triphosphate
1989 Nov
HSL4486
Re: the promotion of DPT-P vaccine
1989 Oct
HSL4488
Re: the promotion of Franol combination for asthma
1989 Oct
HSL4484
Re: the promotion of serrapeptase
1989 Aug
HSL4482
Re: the promotion of buflomedil
1989 Jun
HSL4476
Re: the promotion of nicergoline
1989 May
HSL4463
MaLAM letter follow up—Abbott
MaLAM Newsletter 1989 Feb:1
HSL4462
MaLAM letter follow up—Last gasps for a respiratory stimulant
MaLAM Newsletter 1989 Jan:1
HSL4412
Franklin K.
The pharmaceutical tango
New Physician 1989;38(5):24-28
HSL4101
Re: the promotion of Rogin E
1988 Sep
HSL4082
Re: the promotion of penicillin/streptomycin combination
1988 Feb
HSL3996
Ferguson A.
Commercial pharmaceutical medicine and medicalization: a case study from El Salvador
1988
HSL4030
Pearse WH.
Advertising of prescription drugs
New England Journal of Medicine 1988;319:314
HSL3979
Re: the promotion of trimethoprim/sulphamethoxazole/guaiphenesin/ammonium chloride
1987 Oct
HSL3975
Re: the promotion of flunarizine
1987 Sep
HSL3973
Organon and anabolic steroids
WEMOS pharma group 1987 Aug
HSL3894
Ketelbey JW.
Fenbufen trial in general practice.
N Z Med J 1987 Jun 10;100(825):361
HSL3860
Re: the promotion of amidopyrine/phenylbutazone/prednisolone
1986 Dec
HSL3853
Re: the promotion of arsenic/strychnine
1986 Nov
HSL3850
Re: the promotion of oral streptomycin/chloramphenicol combination
1986 Oct
HSL3847
Re: the promotion of furazolidone/kaolin/pectin
1986 Sep
HSL3841
Re: the promotion of piroxicam
1986 Aug
HSL3839
Re: the promotion of diphenhydramine and ammonium chloride
1986 Jul
HSL3835
Re: the promotion of Primobolan and Fortabol
1986 Mar
HSL3834
Re: the promotion of ibuprofen syrup
1986 Feb
HSL3776
Drugs and the Third World: chloroform sale and hazards—a Malaysian study
Consumers’ Association of Penang 1986
HSL3753
Re: the promotion of Entero-Sediv
1985 Dec 01
HSL3750
Re: the promotion of anabolic steroids for children
1985 Nov 01
HSL3618
Some dodgy claims for pirbuterol (Exirel)--a beta 2 agonist.
Drug Ther Bull. 1984 Sep 10;22(18):70-2
HSL3553
Silverman M, Lee PR, Lydecker M.
The drugging of the Third World.
Int J Health Serv 1982;12(4):585-96
HSL3554
Silverman M, Lee PR, Lydecker M.
Prescriptions for death: the drugging of the Third World
Berkeley: University of California Press; 1982
HSL3468
Hemminki E, Falkum E.
Psychotropic drug registration in the Scandinavian countries: the role of clinical trials.
Soc Sci Med [Med Psychol Med Sociol] 1980 Dec;14A(6):547-59
HSL3460
Ethics and drug ads—a slip up in Bangladesh
1980;208:268-269
HSL3432
Martin RW.
Diuretic equivalence of frusemide preparations
New Zealand Medical Journal 1979;90:209
HSL3385
Kunin CM.
Blunder drug for pneumonia.
N Engl J Med 1977 Jul 14;297(2):113-4
HSL3342
Ruskin A.
Social and regulatory consequences of misleading medical information
Journal of Drug Issues 1976;6(1):50-55
HSL3274
Kales A, Kales JD.
Shortcomings in the evaluation and promotion of hypnotic drugs
New England Journal of Medicine 1975;293:826-827
HSL3253
Wolfe SM.
Scientific evaluations dispute advertising claims
Journal of Drug Issues 1974;4:249-253
HSL2939
Kimmey JR.
Drug efficacy and a journal's responsibility.
Am J Public Health 1972 Apr;62(4):461-2
HSL2938
Greenblatt DJ, Shader RI.
Meprobamate: a study of irrational drug use.
Am J Psychiatry 1971 Apr;127(10):1297-303
HSL3186
Pillard RC.
Drug advertising and the prescribing physician
New Physician 1971;20:183-186